The Embyr Discovery Engine
A comprehensive platform integrating:
knowledge graphs, deep probabilistic analysis models, AI algorithms, and a modular CRISPR toolkit
purpose-built to solve drug discovery's hardest problems.
Single-Cell & Spatial Technologies
Disease biology happens at the cellular level. Our single-cell and spatial transcriptomic capabilities reveal the heterogeneity that bulk methods miss—identifying the specific cell populations driving disease, responding to treatment, or causing adverse effects.
Perturb-seq at Scale
Test hundreds of genetic perturbations simultaneously with single-cell resolution. Our proprietary CRISPR 'Swiss Army Knife' modules enable knockout, knockdown, activation, and base editing—all in a single, massively parallel experiment. The result: functional validation data that would take years to generate with traditional approaches, delivered in weeks.
Multi-Omics Integration
No single data type tells the whole story. We integrate transcriptomic, proteomic, and phenotypic data into unified analyses, connecting genetic perturbations to molecular mechanisms to cellular outcomes.
AI/ML Analysis
Our deep probabilistic models and knowledge graphs don't just analyze data—they generate hypotheses. By integrating public databases, proprietary datasets, and experiment results, our AI identifies patterns that human analysis would never find, prioritizing targets with the highest probability of success.
Automation Infrastructure
Scale and reproducibility aren't optional—they're essential. Our advanced robotic systems process 10,000+ samples simultaneously with 95%+ data quality, delivering results in 48-72 hours. This isn't just faster. It's a fundamentally different approach to genomics.